Deborah Bilder,
MD
Languages Spoken: English, German
Dr. Deborah Bilder is Medical Director of the Neurobehavior HOME Program. In this setting, she provides medical and psychiatric services in a novel medical home program in Salt Lake City, Utah, which serves individuals throughout the lifespan with developmental disabilities. Dr. Bilder also provides psychiatric consultation to the University of Utah’s metabolic genetics clinic for individuals with PKU. She is an Assistant Professor at the University of Utah Department of Psychiatry in the Division of Child and Adolescent Psychiatry. Dr. Bilder received a B.A. degree at Wake Forest University; an M.D degree at Vanderbilt University; and completed her Triple Board (pediatrics, general psychiatry, child and adolescent psychiatry) residency at University of Utah. She is board certified in all three specialties. Following residency, she received certification through pediatrics in Utah Leadership Education in Neurodevelopmental Disabilities. Her research interests include autism epidemiology, autism adult outcomes, and psychiatric complications of PKU.
Clinical Locations
UNI Neurobehavior HOME Program
801-581-5515
Board Certification and Academic Information
| Academic Departments | Psychiatry
-
Associate Professor (Clinical) Educational Psychology - Adjunct Associate Professor Pediatrics - Adjunct Associate Professor |
| Academic Divisions | Child Psychiatry General Pediatrics |
| Board Certification | American Board of Pediatrics (Pediatrics) American Board of Psychiatry & Neurology (Child & Adolescent Psychiatry) American Board of Psychiatry & Neurology (Psychiatry) |
Dr. Deborah Bilder is Medical Director of the Neurobehavior HOME Program. In this setting, she provides medical and psychiatric services in a novel medical home program in Salt Lake City, Utah, which serves individuals throughout the lifespan with developmental disabilities. Dr. Bilder also provides psychiatric consultation to the University of Utah’s metabolic genetics clinic for individuals with PKU. She is an Assistant Professor at the University of Utah Department of Psychiatry in the Division of Child and Adolescent Psychiatry. Dr. Bilder received a B.A. degree at Wake Forest University; an M.D degree at Vanderbilt University; and completed her Triple Board (pediatrics, general psychiatry, child and adolescent psychiatry) residency at University of Utah. She is board certified in all three specialties. Following residency, she received certification through pediatrics in Utah Leadership Education in Neurodevelopmental Disabilities. Her research interests include autism epidemiology, autism adult outcomes, and psychiatric complications of PKU.
Academic Locations
650 Komas
801-581-7952
Board Certification and Academic Information
| Academic Departments | Psychiatry
-
Associate Professor (Clinical) Educational Psychology - Adjunct Associate Professor Pediatrics - Adjunct Associate Professor |
| Academic Divisions | Child Psychiatry General Pediatrics |
| Board Certification | American Board of Pediatrics (Pediatrics) American Board of Psychiatry & Neurology (Child & Adolescent Psychiatry) American Board of Psychiatry & Neurology (Psychiatry) |
Education History
| Other Training | Utah Leadership Education in Neurodevelopmental Disabilities Pediatrics Certification |
| Residency | University of Utah School of Medicine Triple Board Resident |
| Internship | University of Utah School of Medicine Triple Board Intern |
| Professional Medical | Vanderbilt University Medicine M.D. |
| Undergraduate | Wake Forest University School of Medicine German B.A. |
Selected Publications - Journal Articles
Journal Article
- Christensen DL, Maenner MJ, Bilder D, Constantino JN, Daniels J, Durkin MS, Fitzgerald RT, Kurzius-Spencer M, Pettygrove SD, Robinson C, Shenouda J, White T, Zahorodny W, Pazol K, Dietz P (2019). Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 4 Years - Early Autism and Developmental Disabilities Monitoring Network, Seven Sites, United States, 2010, 2012, and 2014. MMWR Surveill Summ, 68(2), 1-19.
- Kirby AV, Bakian AV, Zhang Y, Bilder DA, Keeshin BR, Coon H (2019). A 20-year study of suicide death in a statewide autism population. Autism Research, 12(4), 658-666.
- Longo N, Dimmock D, Levy H, Viau K, Bausell H, Bilder DA, Burton B, Gross C, Northrup H, Rohr F, Sacharow S, Sanchez-Valle A, Stuy M, Thomas J, Vockley J, Zori R, Harding CO (2018). Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria. (Epub ahead of print) Genet Med.
- Christensen DL, Braun KVN, Baio J, Bilder D, Charles J, Constantino JN, Daniels J, Durkin MS, Fitzgerald RT, Kurzius-Spencer M, Lee LC, Pettygrove S, Robinson C, Schulz E, Wells C, Wingate MS, Zahorodny W, Yeargin-Allsopp M (2018). Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012. MMWR Surveill Summ, 65(13), 1-23.
- Bakian AV, Bilder DA, Korgenski EK, Bonkowsky JL (2018). Autism Spectrum Disorder and Neonatal Serum Magnesium Levels in Preterm Infants. Child Neurol Open, 5, 2329048X18800566.
- Thomas J, Levy H, Amato S, Vockley J, Zori R, Dimmock D, Harding CO, Bilder DA, Weng HH, Olbertz J, Merilainen M, Jiang J, Larimore K, Gupta S, Gu Z, Northrup H, PRISM investigators (2018). Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM). Mol Genet Metab, 124(1), 27-38.
- Farley M, Cottle KJ, Bilder D, Viskochil J, Coon H, McMahon W (2017). Mid-life social outcomes for a population-based sample of adults with ASD. Autism Research, 11(1), 142-152.
- Schoser B, Bilder DA, Dimmock D, Gupta D, James ES, Prasad S (2017). The humanistic burden of Pompe disease: are there still unmet needs? A systematic review. BMC Neurol, 17(1), 202.
- Dickerson AS, Rahbar MH, Pearson DA, Kirby RS, Bakian AV, Bilder DA, Harrington RA, Pettygrove S, Zahorodny WM, Moy LA 3rd, Durkin M, Slay Wingate M (2017). Autism spectrum disorder reporting in lower socioeconomic neighborhoods. Autism, 21(4), 470-480.
- Bilder DA, Kobori JA, Cohen-Pfeffer JL, Johnson EM, Jurecki ER, Grant ML (2017). Neuropsychiatric comorbidities in adults with phenylketonuria: A retrospective cohort study. Mol Genet Metab, 121(1), 1-8.
- Bilder DA, Bakian AV, Stevenson DA, Carbone PS, Cunniff C, Goodman AB, McMahon WM, Fisher NP, Viskochil D (2016). Brief Report: The Prevalence of Neurofibromatosis Type 1 among Children with Autism Spectrum Disorder Identified by the Autism and Developmental Disabilities Monitoring Network. J Autism Dev Disord, 46(10), 3369-76.
- Dickerson AS, Rahbar MH, Bakian AV, Bilder DA, Harrington RA, Pettygrove S, Kirby RS, Durkin MS, Han I, Moy LA 3rd, Pearson DA, Wingate MS, Zahorodny WM (2016). Autism spectrum disorder prevalence and associations with air concentrations of lead, mercury, and arsenic. Environ Monit Assess, 188(7), 407.
- Jones KB, Cottle K, Bakian A, Farley M, Bilder D, Coon H, McMahon WM (2015). A description of medical conditions in adults with autism spectrum disorder: A follow-up of the 1980s Utah/UCLA Autism Epidemiologic Study. Autism, 20(5), 551-61.
- Wyrwich KW, Shaffer S, Gries K, Auguste P, Mooney KH, Prasad S, Bilder DA (2016). Content validity of the ADHD Rating Scale (ADHD RS-IV) and Adult ADHD Self-Report Scale (ASRS) in phenylketonuria. Journal of Inborn Errors of Metabolism and Screening, 4, 1-9.
- Viau K, Jones JL, Murtaugh MA, Gren LH, Stanford JB, Bilder DA (2016). Phone-based motivational interviewing to increase self-efficacy in individuals with phenylketonuria. Mol Genet Metab Rep, 6, 27-33.
- Autism and Developmental Disabilities Monitoring Network Surveillance Year 2012 Principal Investigators (2016). Prevalence and characteristics of autism spectrum disorder among children aged 8 years – Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2012. MMWR Surveill Summ, 65(3), 1-23.
- Ruiz LM, Damron M, Jones KB, Weedon D, Carbone PS, Bakian AV, Bilder DA (2016). Antipsychotic Use and Metabolic Monitoring in Individuals with Developmental Disabilities Served in a Medicaid Medical Home. J Autism Dev Disord, 46(6), 1887-1894.
- Bilder DA, Noel JK, Baker ER, Irish W, Chen Y, Merilainen MJ, Prasad S, Winslow BJ (2016). Systematic Review and Meta-Analysis of Neuropsychiatric Symptoms and Executive Functioning in Adults With Phenylketonuria. Dev Neuropsychol, 41(4), 245-260.
- Viau KS, Jones JL, Murtaugh MA, Gren LH, Stanford JB, Bilder DA (2016). Phone-based motivational interviewing to increase self-efficacy in individuals with phenylketonuria. 6, 27-33.
- Gray DD, Bilder DA, Leonard HL, Anders TF (2006). Triple board training and new "portals" into child psychiatry training. Child Adolesc Psychiatr Clin N Am, 16(1), 55-66, viii.
Video/Film/CD/Web/Podcast
- Bilder D, Lainhart J (2004). "Autism Module", Utah Collaborative Medical Home Project [Web]. Utah Collaborative Medical Home Project. Available: http://medhome.med.utah.edu/diag/diagnosis.cfm?diag_id=20&.